Find generic entry opportunities
Anticipate generic drug launch
Manage your formulary budget
Drug patents …
… from Kazakhstan to Kalamazoo
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Proactively manage your pharmacy inventory
|Title:||Melt-extruded orally administrable opioid formulations|
|Abstract:||Bioavailable sustained release oral opioid analgesic dosage forms, comprising a plurality of multiparticulates produced via melt extrusion techniques are disclosed.|
|Inventor(s):||Oshlack; Benjamin (New York, NY), Chasin; Mark (Manalapan, NJ), Huang; Hua-Pin (Englewood Cliffs, NJ), Sackler; David (Greenwich, CT)|
|Assignee:||Euro-Celtique, S.A. (Luxembourg, LU)|
Patent Claim Types:|
see list of patent claims
|Composition; Formulation; Compound; Dosage form; Use;|
Back Citations: 252nd percentile
Forward Citations: 3rd percentile
|Patent Number||Expiration Date|
|6,743,442||June 01, 2016|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.